|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.60 EUR | -0.99% |
|
-6.46% | -10.48% |
| 14/01 | Frankfurt Stocks Close: DAX Ends Impressive Record-Breaking Streak | DP |
| 14/01 | FMC FRESENIUS MEDICAL CARE AG : UBS keeps a Sell rating | ZD |
| Capitalization | 1.03TCr 1.2TCr 961.83Cr 895.07Cr 1.67TCr 1,08700Cr 1.8TCr 11TCr 4.35TCr 52TCr 4.51TCr 4.42TCr 1,90500Cr | P/E ratio 2025 * |
11.8x | P/E ratio 2026 * | 9.71x |
|---|---|---|---|---|---|
| Enterprise value | 1.91TCr 2.23TCr 1.78TCr 1.66TCr 3.09TCr 2,01100Cr 3.33TCr 20TCr 8.05TCr 96TCr 8.35TCr 8.18TCr 3,52400Cr | EV / Sales 2025 * |
0.98x | EV / Sales 2026 * | 0.93x |
| Free-Float |
67.83% | Yield 2025 * |
3.83% | Yield 2026 * | 4.12% |
Last Transcript: Fresenius Medical Care AG
| 1 day | -1.01% | ||
| 1 week | -6.46% | ||
| Current month | -10.48% | ||
| 1 month | -8.71% | ||
| 3 months | -20.74% | ||
| 6 months | -21.22% | ||
| Current year | -10.48% |
| 1 week | 36.23 |  | 40.98 |
| 1 month | 36.23 | | 40.98 |
| Current year | 36.23 | | 40.98 |
| 1 year | 36.23 | | 54.02 |
| 3 years | 30.16 | | 54.02 |
| 5 years | 25.95 | | 71.14 |
| 10 years | 25.95 | | 93.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 58 | 06/12/2022 |
Martin Fischer
DFI | Director of Finance/CFO | 49 | 01/10/2023 |
Jörg Häring
CMP | Compliance Officer | 56 | 01/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 59 | 12/05/2016 |
A. Sorensen
BRD | Director/Board Member | 64 | 20/05/2021 |
Michael Sen
CHM | Chairman | 57 | 14/07/2023 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 7.48% | 0 M€ | |
| -.--% | 0.8% | 0 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.99% | -6.46% | -17.46% | +7.51% | 1.2TCr | |
| +0.28% | -0.06% | +56.32% | +85.33% | 11TCr | |
| -0.08% | -1.95% | +51.57% | -11.57% | 10TCr | |
| -3.21% | +0.58% | +41.40% | +75.27% | 3.41TCr | |
| -0.46% | +4.94% | -13.25% | +18.14% | 2.43TCr | |
| +0.63% | +3.37% | +10.94% | +3.34% | 2.17TCr | |
| +0.39% | +5.38% | +24.60% | +26.95% | 2.08TCr | |
| +1.46% | -2.89% | +51.87% | +272.24% | 1.72TCr | |
| -0.30% | -1.20% | +48.59% | +53.77% | 1.65TCr | |
| +0.81% | -5.06% | +9.19% | +36.79% | 1.24TCr | |
| Average | -0.19% | +0.61% | +26.38% | +56.78% | 3.69TCr | |
| Weighted average by Cap. | -0.18% | +1.20% | +40.06% | +48.52% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.96TCr 2.28TCr 1.82TCr 1.7TCr 3.16TCr 2,05900Cr 3.41TCr 21TCr 8.24TCr 98TCr 8.55TCr 8.38TCr 3,60900Cr | 2.02TCr 2.35TCr 1.88TCr 1.75TCr 3.26TCr 2,12000Cr 3.51TCr 22TCr 8.49TCr 1,01400Cr 8.81TCr 8.63TCr 3,71700Cr |
| Net income | 90Cr 105.11Cr 84Cr 78Cr 145.84Cr 9.49TCr 157.22Cr 965.54Cr 379.85Cr 4.54TCr 394.22Cr 386.09Cr 17TCr | 107.6Cr 125.39Cr 100.19Cr 93Cr 173.98Cr 11TCr 187.55Cr 1.15TCr 453.14Cr 5.42TCr 470.28Cr 460.59Cr 20TCr |
| Net Debt | 878.15Cr 1.02TCr 817.63Cr 760.87Cr 1.42TCr 92TCr 1.53TCr 9.4TCr 3.7TCr 44TCr 3.84TCr 3.76TCr 1,61900Cr | 835.17Cr 973.27Cr 777.61Cr 723.63Cr 1.35TCr 88TCr 1.46TCr 8.94TCr 3.52TCr 42TCr 3.65TCr 3.57TCr 1,54000Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | 36.46 € | -1.38% | 9,54,701 |
| 14/26/14 | 36.97 € | -6.02% | 28,23,764 |
| 13/26/13 | 39.34 € | -3.20% | 8,56,131 |
| 12/26/12 | 40.64 € | +2.89% | 8,35,009 |
| 09/26/09 | 39.50 € | +1.26% | 8,14,286 |
Delayed Quote Xetra, January 15, 2026 at 09:03 pm IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FME Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition